Avion Wealth’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-660
Closed – – 1456
2026
Q2
$0 Hold
660
– – ﹤0.01% 1471
2026
Q1
$1K Hold
660
– – ﹤0.01% 988
2025
Q4
$0 Hold
660
– – ﹤0.01% 1282
2025
Q3
$1K Hold
660
– – ﹤0.01% 967
2025
Q2
$0 Hold
660
– – ﹤0.01% 1229
2025
Q1
$0 Buy
+660
New +$760 ﹤0.01% 1058

Other funds holding CHRS

Avion Wealth's CHRS Position: Q3 2026 in Review

Avion Wealth sold out of Coherus Oncology (CHRS) in Q3 2026, closing a stake of 660 shares.

Avion Wealth first reported a position in CHRS in Q1 2025 and held it in 6 quarters. The position peaked at $1K in Q1 2026. 59 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • Avion Wealth reported no remaining Coherus Oncology position as of Q3 2026 after selling out during the quarter.
  • Avion Wealth sold 660 Coherus Oncology shares in Q3 2026.
  • Avion Wealth first reported a position in Coherus Oncology in Q1 2025 and held it in 6 quarters.
  • Avion Wealth's Coherus Oncology position peaked at $1K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.